Acyclovir
- Product NDC
- 50090-6335
- 11-digit product format
- 500906335
- Labeler code
- 50090
- Product ID
- 50090-6335_d3a10247-e6a9-4247-b1cc-87092d2b6033
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA209366
- Marketing category
- ANDA
- Marketing start
- 2020-08-15
- Substance
- ACYCLOVIR
- Active strength
- 800 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| X4HES1O11F | ACYCLOVIR | 59277-89-3 | ACYCLOVIR |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-6335-0 | 50090633500 | 35 TABLET in 1 BOTTLE (50090-6335-0) | 35 tablet | 2023-01-18 | No | No | Historical |
| 50090-6335-2 | 50090633502 | 70 TABLET in 1 BOTTLE (50090-6335-2) | 70 tablet | 2023-01-18 | No | No | Historical |
| 50090-6335-3 | 50090633503 | 40 TABLET in 1 BOTTLE (50090-6335-3) | 40 tablet | 2023-01-18 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Acyclovir Tablets, USP | A-S Medication Solutions | 2023-02-06 | HUMAN PRESCRIPTION DRUG LABEL | 4 |